GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Telo Genomics Corp (TSXV:TELO) » Definitions » Market Cap

Telo Genomics (TSXV:TELO) Market Cap : C$10.00 Mil (As of Apr. 07, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Telo Genomics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Telo Genomics's share price for the quarter that ended in Dec. 2024 was C$0.13. Telo Genomics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 100.02 Mil. Therefore, Telo Genomics's market cap for the quarter that ended in Dec. 2024 was C$13.00 Mil.

Telo Genomics's quarterly market cap declined from Jun. 2024 (C$13.79 Mil) to Sep. 2024 (C$11.18 Mil) but then increased from Sep. 2024 (C$11.18 Mil) to Dec. 2024 (C$13.00 Mil).

Telo Genomics's annual market cap declined from Jun. 2022 (C$21.24 Mil) to Jun. 2023 (C$20.99 Mil) and declined from Jun. 2023 (C$20.99 Mil) to Jun. 2024 (C$13.79 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Telo Genomics's Enterprise Value for Today is C$8.74 Mil.


Telo Genomics Market Cap Historical Data

The historical data trend for Telo Genomics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telo Genomics Market Cap Chart

Telo Genomics Annual Data
Trend Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.91 27.77 21.24 20.99 13.79

Telo Genomics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.26 8.20 13.79 11.18 13.00

Competitive Comparison of Telo Genomics's Market Cap

For the Diagnostics & Research subindustry, Telo Genomics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Telo Genomics's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Telo Genomics's Market Cap distribution charts can be found below:

* The bar in red indicates where Telo Genomics's Market Cap falls into.


;
;

Telo Genomics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Telo Genomics's Market Cap for the fiscal year that ended in Jun. 2024 is calculated as

Market Cap (A: Jun. 2024 )=Share Price (A: Jun. 2024 )*Shares Outstanding (EOP) (A: Jun. 2024 )
=C$0.185*74.560
=C$13.79

Telo Genomics's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=C$0.13*100.019
=C$13.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Telo Genomics  (TSXV:TELO) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Telo Genomics Market Cap Related Terms

Thank you for viewing the detailed overview of Telo Genomics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Telo Genomics Business Description

Traded in Other Exchanges
Address
101 College Street, Suite 200, MaRS Centre, South Tower, Toronto, ON, CAN, M5G 1L7
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in developing diagnostic and prognostic products that may save lives, improve the quality of life, and reduce the cost of care associated with numerous diseases that display genomic instability. The company has a single operating segment, focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions.
Executives
Kristan Joseph Weinberg Senior Officer
William John Meekison Director
Hugh Rogers Director

Telo Genomics Headlines

From GuruFocus